Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study-Reference-Cited by-同舟云学术

Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study

Published:2021-09 Issue:9 Volume:27 Page:788-794
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Ram Ron,Hagin David,Kikozashvilli Nino,Freund Tal,Amit Odelia,Bar-On Yael,Beyar-Katz Ofrat,Shefer Gabi,Moshiashvili Miguel Morales,Karni Chen,Gold Ronit,Kay Sigi,Glait-Santar Chen,Eshel Rinat,Perry Chava,Avivi Irit,Apel Arie,Benyamini Noam,Shasha David,Ben-Ami Ronen

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference20 articles.

1. COVID-19 in transplant recipients: the Spanish experience;Coll;Am J Transplant,2021

2. Risk factors and outcome of COVID-19 in patients with hematological malignancies;Piñana;Exp Hematol Oncol,2020

3. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

4. A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation;Karras;Biol Blood Marrow Transplant,2013

5. Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients;Dhedin;Vaccine,2014

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19;Seminars in Hematology;2024-08

2. Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipients;International Journal of Hematology;2024-06-06

3. Infections associated with CAR‐T cell therapy in patients with relapsed refractory multiple myeloma: Risks and prevention strategies;Cancer Medicine;2024-06

4. SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study;Clinical Infectious Diseases;2024-05-27

5. Vaccination of Adults With Cancer: ASCO Guideline;Journal of Clinical Oncology;2024-05-10